Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 20;9(5):e97833.
doi: 10.1371/journal.pone.0097833. eCollection 2014.

Molecular typing of MRSA and of clinical Staphylococcus aureus isolates from Iaşi, Romania

Affiliations

Molecular typing of MRSA and of clinical Staphylococcus aureus isolates from Iaşi, Romania

Stefan Monecke et al. PLoS One. .

Abstract

Romania is one of the countries with the highest prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the world. To obtain data on affiliation of MRSA to strains and clonal complexes and on the population of methicillin susceptible S. aureus (MSSA), clinical isolates from bloodstream infections, skin and soft tissue infections as well as from screening swabs were collected at hospitals in Ia?i, a city in the North-Eastern part of Romania. Isolates were characterised by microarray hybridisation. Nearly half of all isolates (47%), and about one third (34%) of bloodstream isolates were MRSA. The prevalence of the Panton-Valentine leukocidin (PVL) was also high (31% among MRSA, 14% among MSSA). The most common MRSA strain was a PVL-negative CC1-MRSA-IV that might have emerged locally, as a related MSSA was also common. PVL-positive CC8-MRSA-IV ("USA300") and PVL-negative ST239-like MRSA-III were also frequently found while other MRSA strains were only sporadically detected. Among MSSA, PVL-positive CC121 as well as PVL-negative CC1, CC22 and CC45 predominated. Although this study provides only a snapshot of S. aureus/MRSA epidemiology in Romania, it confirms the high burden of MRSA and PVL on Romanian healthcare settings.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: E. Müller, S. Monecke and R. Ehricht are employees of Alere Technologies, the company that manufactures the microarrays also used in this study. This has no influence on study design, data collection and analysis, and this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare that no competing interests exist.

Similar articles

Cited by

References

    1. Bara AC, van den Heuvel WJ, Maarse JA (2002) Reforms of health care system in Romania. Croat Med J 43: 446–452. - PubMed
    1. Holt E (2010) Romania’s health system lurches into new crisis. Lancet 376: 1211–1212. - PubMed
    1. Krcmery V, Gould IM (1999) Antibiotic policies in Central/Eastern Europe (CEE) after 1990. J Hosp Infect 43 Suppl: S269–274. - PubMed
    1. Lakey CK, Nicholas PK, Wolf KA, Leuner JDM (1996) Health care and nursing in Romania. Journal of Advanced Nursing 23: 1045–1049. - PubMed
    1. Dorneanu O, Miftode E, Vremeră T, Năstase E, Filip O, et al. (2006) Prevalence and characteristics of Staphylococcus aureus isolated from infections in Northeast Romania. Journal of Preventive Medicine 14: 66–70.

Publication types

MeSH terms

Substances